Quest Diagnostics Incorporated (DGX)
Return on equity (ROE)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 854,000 | 763,000 | 794,000 | 793,000 | 946,000 | 1,235,000 | 1,484,000 | 1,881,000 | 1,995,000 | 2,184,000 | 2,247,000 | 1,801,000 | 1,431,000 | 1,105,000 | 752,000 | 793,000 | 858,000 | 732,000 | 730,000 | 723,000 |
Total stockholders’ equity | US$ in thousands | 6,307,000 | 6,425,000 | 6,249,000 | 6,050,000 | 5,893,000 | 6,235,000 | 6,411,000 | 6,377,000 | 6,444,000 | 6,392,000 | 5,899,000 | 6,745,000 | 6,759,000 | 6,400,000 | 5,831,000 | 5,657,000 | 5,641,000 | 5,605,000 | 5,459,000 | 5,290,000 |
ROE | 13.54% | 11.88% | 12.71% | 13.11% | 16.05% | 19.81% | 23.15% | 29.50% | 30.96% | 34.17% | 38.09% | 26.70% | 21.17% | 17.27% | 12.90% | 14.02% | 15.21% | 13.06% | 13.37% | 13.67% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $854,000K ÷ $6,307,000K
= 13.54%
Quest Diagnostics, Inc.'s return on equity (ROE) has exhibited fluctuations over the past eight quarters. The ROE for Q4 2023 was 13.48%, which was lower compared to the previous quarter but relatively consistent with the results from Q2 and Q1 2023. However, it showed a decline from the previous year's Q4 figure of 15.99%.
The trend in ROE for Quest Diagnostics, Inc. demonstrates a gradual decrease over the past two years, with Q4 2022 reflecting the highest ROE at 29.39%. The subsequent quarters in 2022 also displayed robust ROE figures, but a diminishing trend is observed from Q2 2022 onwards.
Overall, the declining trend in ROE indicates potential challenges in generating profits relative to the shareholders' equity, which may require further analysis to understand the underlying factors influencing the company's financial performance.
Peer comparison
Dec 31, 2023